Employees are often a company’s most credible ambassadors. Effective internal communications help ensure teams understand the organisation’s strategy, remain engaged during periods of change and are aligned around common goals.

Drawing on experience leading communications and change programmes within global life sciences organisations, we help companies communicate clearly during periods of growth, transformation, restructuring and integration. We work with leadership teams to develop compelling internal narratives, engage employees and ensure strategic priorities are understood throughout the organisation.

As a member of AstraZeneca’s Global Product & Portfolio Strategy leadership team, Katja supported major organisational transformation initiatives, including the company’s shift towards scientific leadership and the integration of a new business unit.

Services

  • Internal communications strategy
  • Change communications
  • Employee engagement programmes
  • Leadership communications
  • Internal messaging & content development
  • Town halls & employee events
  • Presentation development
  • Leadership coaching
  • Organisational transformation support
  • Culture & values communications

Case Studies

Adalyon | Optimising clinical trials using speech biomarkers

Raising visibility for a speech biomarker innovator through strategic positioning, media outreach and high-impact industry engagement.

Advent Life Sciences

Showcasing the significance of two new funds

Amphista Therapeutics

Announcing the company’s Series A financing, leading to raised awareness with potential partners, investors and employees.

Amphista Therapeutics: Series B Financing

Announcing the company's Series B financing, which will be used to accelerate the growing pipeline of potent and selective bifunctional molecules and to extend its proprietary TPD platform.

Anocca

Announcing the company's strategic collaboration with Shinobi Therapeutics to to develop allogeneic TCR-T cell therapies in oncology

AstraZeneca

Positioning the Company as a Partner of Choice as well as facilitating an Internal Change Management Programme.

BC Platforms

Positioning the company as a thought leader in precision medicine raising awareness with customers and investors.

Epitopea Strategic Cancer Collaboration with MSD(Merck)

Announcing the company's strategic cancer collaboration with major global pharma company, positioning client as a pioneer in developing off-the-shelf immunotherapies.

Epitopea USD $31 Million Pre-Series A Financing

Supporting Epitopea’s $31M Pre-Series A financing with high-impact media coverage, raising visibility for CryptoMap™ and strengthening investor and partner engagement.

ExeVir Bio EIB funding case study

Announcing the company's 25 million Euro financing from EIB to advance ExeVir’s COVID19 therapeutic

Igyxos: Raising the profile of a novel infertility treatment

Positioning Igyxos as a thought leader in monoclonal-based fertility innovation and elevating its profile ahead of clinical and investor milestones.

IRBM

Positioning the Company as a leading CDMO and highlighting their group Advaxia Biologics.

Adalyon | Optimising clinical trials using speech biomarkers

Raising visibility for a speech biomarker innovator through strategic positioning, media outreach and high-impact industry engagement.

Advent Life Sciences

Showcasing the significance of two new funds

Amphista Therapeutics

Announcing the company’s Series A financing, leading to raised awareness with potential partners, investors and employees.

Amphista Therapeutics: Series B Financing

Announcing the company's Series B financing, which will be used to accelerate the growing pipeline of potent and selective bifunctional molecules and to extend its proprietary TPD platform.

Anocca

Announcing the company's strategic collaboration with Shinobi Therapeutics to to develop allogeneic TCR-T cell therapies in oncology

AstraZeneca

Positioning the Company as a Partner of Choice as well as facilitating an Internal Change Management Programme.

BC Platforms

Positioning the company as a thought leader in precision medicine raising awareness with customers and investors.

Epitopea Strategic Cancer Collaboration with MSD(Merck)

Announcing the company's strategic cancer collaboration with major global pharma company, positioning client as a pioneer in developing off-the-shelf immunotherapies.

Epitopea USD $31 Million Pre-Series A Financing

Supporting Epitopea’s $31M Pre-Series A financing with high-impact media coverage, raising visibility for CryptoMap™ and strengthening investor and partner engagement.

ExeVir Bio EIB funding case study

Announcing the company's 25 million Euro financing from EIB to advance ExeVir’s COVID19 therapeutic

Igyxos: Raising the profile of a novel infertility treatment

Positioning Igyxos as a thought leader in monoclonal-based fertility innovation and elevating its profile ahead of clinical and investor milestones.

IRBM

Positioning the Company as a leading CDMO and highlighting their group Advaxia Biologics.

Clients